Cardiology
MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension.
Castoldi G, Di Gioia CR, Bombardi C, Catalucci D, Corradi B, Gualazzi MG, Leopizzi M, Mancini M, Zerbini G, Condorelli G, Stella A.
J Cell Physiol. 2012 Feb;227(2):850-6.
Physiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms.
Ellison GM, Waring CD, Vicinanza C, Torella D.
Heart. 2012 Jan;98(1):5-10.
Cardiac insulin resistance and microRNA modulators.
Pulakat L, Aroor AR, Gul R, Sowers JR.
Exp Diabetes Res. 2012;2012:654904.
Deal watch: microRNA collaboration to target cardiovascular disease pathways.
[No authors listed]
Nat Rev Drug Discov. 2011 Dec 1;10(12):890.
Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.
Drake JI, Bogaard HJ, Mizuno S, Clifton B, Xie B, Gao Y, Dumur CI, Fawcett P, Voelkel NF, Natarajan R.
Am J Respir Cell Mol Biol. 2011 Dec;45(6):1239-47.
Serum response factor regulates expression of phosphatase and tensin homolog through a microRNA network in vascular smooth muscle
cells.
Horita HN, Simpson PA, Ostriker A, Furgeson S, Van Putten V, Weiser-Evans MC, Nemenoff RA.
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2909-19.
Purification of high-quality micro RNA from the heart tissue.
Faragó N, Zvara A, Varga Z, Ferdinandy P, Puskás LG.
Acta Biol Hung. 2011 Dec;62(4):413-25.
Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2.
Wu C, So J, Davis-Dusenbery BN, Qi HH, Bloch DB, Shi Y, Lagna G, Hata A.
Mol Cell Biol. 2011 Dec;31(23):4760-74.
Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs.
Marques FZ, Campain AE, Tomaszewski M, Zukowska-Szczechowska E, Yang YH, Charchar FJ, Morris BJ.
Hypertension. 2011 Dec;58(6):1093-8.
MicroRNA-processing enzyme Dicer is required in epicardium for coronary vasculature development.
Singh MK, Lu MM, Massera D, Epstein JA.
J Biol Chem. 2011 Nov 25;286(47):41036-45.
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure.
Ramani R, Vela D, Segura A, McNamara D, Lemster B, Samarendra V, Kormos R, Toyoda Y, Bermudez C, Frazier OH, Moravec CS,
Gorcsan J 3rd, Taegtmeyer H, McTiernan CF.
J Am Coll Cardiol. 2011 Nov 22;58(22):2270-8.
Myocardial expression levels of micro-ribonucleic acids in patients with left ventricular assist devices signature of myocardial recovery,
signature of reverse remodeling, or signature with no name?
Mann DL, Burkhoff D.
J Am Coll Cardiol. 2011 Nov 22;58(22):2279-81.
The hsa-miR-5739 modulates the endoglin network in endothelial cells derived from human embryonic stem cells.
Yoo JK, Kim J, Choi SJ, Kim CH, Lee DR, Chung HM, Kim JK.
Biochem Biophys Res Commun. 2011 Nov 18;415(2):258-62.
Ischemia and reperfusion--from mechanism to translation.
Eltzschig HK, Eckle T.
Nat Med. 2011 Nov 7;17(11):1391-401.
A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia.
Kelly M, Bagnall RD, Peverill RE, Donelan L, Corben L, Delatycki MB, Semsarian C.
J Mol Cell Cardiol. 2011 Nov;51(5):848-54.
Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome.
Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC, Thum T.
J Mol Cell Cardiol. 2011 Nov;51(5):872-5.
MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial
growth factor receptor-2 and fibroblast growth factor receptor-1.
Chamorro-Jorganes A, Araldi E, Penalva LO, Sandhu D, Fernández-Hernando C, Suárez Y.
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2595-606.
MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1.
Ramirez CM, Dávalos A, Goedeke L, Salerno AG, Warrier N, Cirera-Salinas D, Suárez Y, Fernández-Hernando C.
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2707-14.
Identification of cardiovascular microRNA targetomes.
Fiedler J, Gupta SK, Thum T.
J Mol Cell Cardiol. 2011 Nov;51(5):674-81.
MicroRNAs looping around angiogenesis.
Fiedler J, Thum T.
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2367-8.
MicroRNA regulation of cardiovascular functions.
Sessa WC.
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2369.
Micromanaging vascular smooth muscle cell differentiation and phenotypic modulation.
Davis-Dusenbery BN, Wu C, Hata A.
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2370-7.
MicroRNA modulation of cholesterol homeostasis.
Fernández-Hernando C, Moore KJ.
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2378-82.
Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?
Fichtlscherer S, Zeiher AM, Dimmeler S.
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2383-90.
MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt
pathway in the infarcted heart.
Glass C, Singla DK.
Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2038-49.
Profile of microRNAs differentially produced in hearts from patients with hypertrophic cardiomyopathy and sarcomeric mutations.
Palacín M, Reguero JR, Martín M, Díaz Molina B, Morís C, Alvarez V, Coto E.
Clin Chem. 2011 Nov;57(11):1614-6.
MicroRNA-29 in aortic dilation: implications for aneurysm formation.
Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, Horrevoets AJ, Vinciguerra M, Rosenthal N, Sciacca S, Pilato M, van Heijningen
P, Essers J, Brandes RP, Zeiher AM, Dimmeler S.
Circ Res. 2011 Oct 28;109(10):1115-9.
Modulating the MicroRNArchitecture of an aging aorta.
O'Rourke JR, Olson EN.
Circ Res. 2011 Oct 28;109(10):1098-9.
Letter by Sluijter et al regarding article, "Human cardiac stem cell differentiation is regulated by a mircrine mechanism".
Sluijter JP, Doevendans PA, Goumans MJ.
Circulation. 2011 Oct 25;124(17):e456
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.
Rayner KJ, Esau CC, Hussain FN, McDaniel AL, Marshall SM, van Gils JM, Ray TD, Sheedy FJ, Goedeke L, Liu X, Khatsenko OG,
Kaimal V, Lees CJ, Fernandez-Hernando C, Fisher EA, Temel RE, Moore KJ.
Nature. 2011 Oct 19;478(7369):404-7.
miR-155 inhibits expression of the MEF2A protein to repress skeletal muscle differentiation.
Seok HY, Tatsuguchi M, Callis TE, He A, Pu WT, Wang DZ.
J Biol Chem. 2011 Oct 14;286(41):35339-46.
Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.
Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN, van Rooij E.
Circulation. 2011 Oct 4;124(14):1537-47.
MiR-483-5p controls angiogenesis in vitro and targets serum response factor.
Qiao Y, Ma N, Wang X, Hui Y, Li F, Xiang Y, Zhou J, Zou C, Jin J, Lv G, Jin H, Gao X.
FEBS Lett. 2011 Oct 3;585(19):3095-100.
Toll-like receptors: new players in myocardial ischemia/reperfusion injury.
Ha T, Liu L, Kelley J, Kao R, Williams D, Li C.
Antioxid Redox Signal. 2011 Oct 1;15(7):1875-93.
MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension.
Wu WH, Hu CP, Chen XP, Zhang WF, Li XW, Xiong XM, Li YJ.
Am J Hypertens. 2011 Oct;24(10):1087-93.
miR-125b regulates calcification of vascular smooth muscle cells.
Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC.
Am J Pathol. 2011 Oct;179(4):1594-600.
MicroRNAs: new players in cardiac injury and protection.
Kukreja RC, Yin C, Salloum FN.
Mol Pharmacol. 2011 Oct;80(4):558-64.
microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects.
Mutharasan RK, Nagpal V, Ichikawa Y, Ardehali H.
Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1519-30.
Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells.
Kotlo KU, Hesabi B, Danziger RS.
Am J Physiol Cell Physiol. 2011 Oct;301(4):C929-37.
[Progress in studies on microRNAs regulation of cardiac development].
Wang F, Gui YH.
Zhonghua Er Ke Za Zhi. 2010 Oct;48(10):791-4.
MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo.
Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD, Bochicchio A, Vicinanza C, Aquila I, Curcio A, Condorelli G, Indolfi C.
Circ Res. 2011 Sep 30;109(8):880-93.
Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program
involving micro-RNA-132.
Katare R, Riu F, Mitchell K, Gubernator M, Campagnolo P, Cui Y, Fortunato O, Avolio E, Cesselli D, Beltrami AP, Angelini G, Emanueli C,
Madeddu P.
Circ Res. 2011 Sep 30;109(8):894-906.
MicroRNA133a: a new variable in vascular smooth muscle cell phenotypic switching.
Miano JM, Small EM.
Circ Res. 2011 Sep 30;109(8):825-7.
Hydrogen sulphide inhibits cardiomyocyte hypertrophy by up-regulating miR-133a.
Liu J, Hao DD, Zhang JS, Zhu YC.
Biochem Biophys Res Commun. 2011 Sep 23;413(2):342-7.
Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation.
Hu S, Huang M, Nguyen PK, Gong Y, Li Z, Jia F, Lan F, Liu J, Nag D, Robbins RC, Wu JC.
Circulation. 2011 Sep 13;124(11 Suppl):S27-34.
MicroRNA-23 restricts cardiac valve formation by inhibiting Has2 and extracellular hyaluronic acid production.
Lagendijk AK, Goumans MJ, Burkhard SB, Bakkers J.
Circ Res. 2011 Sep 2;109(6):649-57.
MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes.
Porrello ER, Johnson BA, Aurora AB, Simpson E, Nam YJ, Matkovich SJ, Dorn GW 2nd, van Rooij E, Olson EN.
Circ Res. 2011 Sep 2;109(6):670-9.
Micro-managing myocyte mitosis.
Li D, Epstein JA.
Circ Res. 2011 Sep 2;109(6):611-3.
Regulation of ion transport by microRNAs.
Elvira-Matelot E, Jeunemaitre X, Hadchouel J.
Curr Opin Nephrol Hypertens. 2011 Sep;20(5):541-6.
MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes.
Zhang J, Chintalgattu V, Shih T, Ai D, Xia Y, Khakoo AY.
J Mol Cell Cardiol. 2011 Sep;51(3):337-46.
Therapeutic use of microRNAs in myocardial diseases.
Latronico MV, Condorelli G.
Curr Heart Fail Rep. 2011 Sep;8(3):193-7.
Discovery of shear- and side-specific mRNAs and miRNAs in human aortic valvular endothelial cells.
Holliday CJ, Ankeny RF, Jo H, Nerem RM.
Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H856-67.
A unique microRNA signature associated with plaque instability in humans.
Cipollone F, Felicioni L, Sarzani R, Ucchino S, Spigonardo F, Mandolini C, Malatesta S, Bucci M, Mammarella C, Santovito D, de Lutiis F,
Marchetti A, Mezzetti A, Buttitta F.
Stroke. 2011 Sep;42(9):2556-63.
MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities.
Wang M, Li W, Chang GQ, Ye CS, Ou JS, Li XX, Liu Y, Cheang TY, Huang XL, Wang SM.
Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2044-53.
MicroRNA 21 "shapes" vascular smooth muscle behavior through regulating tropomyosin 1.
Baker AH.
Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):1941-2.
Transforming growth factor-beta1 (TGF-beta1) utilizes distinct pathways for the transcriptional activation of microRNA 143/145 in human
coronary artery smooth muscle cells.
Long X, Miano JM.
J Biol Chem. 2011 Aug 26;286(34):30119-29.
Coordinated post-transcriptional regulation of Hsp70.3 gene expression by microRNA and alternative polyadenylation.
Tranter M, Helsley RN, Paulding WR, McGuinness M, Brokamp C, Haar L, Liu Y, Ren X, Jones WK.
J Biol Chem. 2011 Aug 26;286(34):29828-37.
The role of microRNAs in cholesterol efflux and hepatic lipid metabolism.
Moore KJ, Rayner KJ, Suárez Y, Fernández-Hernando C.
Annu Rev Nutr. 2011 Aug 21;31:49-63.
MicroRNA-24 regulates vascularity after myocardial infarction.
Fiedler J, Jazbutyte V, Kirchmaier BC, Gupta SK, Lorenzen J, Hartmann D, Galuppo P, Kneitz S, Pena JT, Sohn-Lee C, Loyer X,
Soutschek J, Brand T, Tuschl T, Heineke J, Martin U, Schulte-Merker S, Ertl G, Engelhardt S, Bauersachs J, Thum T.
Circulation. 2011 Aug 9;124(6):720-30.
Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a.
Wu W, Xiao H, Laguna-Fernandez A, Villarreal G Jr, Wang KC, Geary GG, Zhang Y, Wang WC, Huang HD, Zhou J, Li YS, Chien S, Garcia-
Cardena G, Shyy JY.
Circulation. 2011 Aug 2;124(5):633-41.
Crippling of Krüppel (-like factor 2) by bad flow portends a miRky day for endothelial function.
Irani K.
Circulation. 2011 Aug 2;124(5):541-3.
Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21.
Zhang Y, Wang Y, Wang X, Zhang Y, Eisner GM, Asico LD, Jose PA, Zeng C.
J Hypertens. 2011 Aug;29(8):1560-8.
Delaying vascular aging with Chinese medicine: implications from an overview of the p53 and miR-34s family.
Wang M, Lei Y.
Chin J Integr Med. 2011 Aug;17(8):635-9.
miR-146a is modulated in human endothelial cell with aging.
Vasa-Nicotera M, Chen H, Tucci P, Yang AL, Saintigny G, Menghini R, Mahè C, Agostini M, Knight RA, Melino G, Federici M.
Atherosclerosis. 2011 Aug;217(2):326-30.
Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced
pluripotent stem cells.
Quattrocelli M, Palazzolo G, Agnolin I, Martino S, Bouché M, Anastasia L, Sampaolesi M.
J Cell Biochem. 2011 Aug;112(8):2006-14.
Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry.
Schneider M, Andersen DC, Silahtaroglu A, Lyngbæk S, Kauppinen S, Hansen JL, Sheikh SP.
J Mol Histol. 2011 Aug;42(4):289-99.
MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis.
Hulsmans M, De Keyzer D, Holvoet P.
FASEB J. 2011 Aug;25(8):2515-27.
Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-
angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).
Fernandes T, Hashimoto NY, Magalhães FC, Fernandes FB, Casarini DE, Carmona AK, Krieger JE, Phillips MI, Oliveira EM.
Hypertension. 2011 Aug;58(2):182-9.
Biogenesis and regulation of cardiovascular microRNAs.
Bauersachs J, Thum T.
Circ Res. 2011 Jul 22;109(3):334-47.
Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection.
Li S, Zhu J, Zhang W, Chen Y, Zhang K, Popescu LM, Ma X, Lau WB, Rong R, Yu X, Wang B, Li Y, Xiao C, Zhang M, Wang S, Yu L, Chen
AF, Yang X, Cai J.
Circulation. 2011 Jul 12;124(2):175-84.
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.
Rayner KJ, Sheedy FJ, Esau CC, Hussain FN, Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y, Fernandez-
Hernando C, Fisher EA, Moore KJ.
J Clin Invest. 2011 Jul 1;121(7):2921-31.
Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice.
Diao X, Shen E, Wang X, Hu B.
Mol Med Report. 2011 Jul-Aug;4(4):633-40.
MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1.
Liu J, van Mil A, Vrijsen K, Zhao J, Gao L, Metz CH, Goumans MJ, Doevendans PA, Sluijter JP.
J Cell Mol Med. 2011 Jul;15(7):1474-82.
Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjunction with clinical parameters, predict
regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis.
Villar AV, Merino D, Wenner M, Llano M, Cobo M, Montalvo C, García R, Martín-Durán R, Hurlé JM, Hurlé MA, Nistal JF.
Heart. 2011 Jul;97(14):1132-7.
MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular
cell damage.
Togliatto G, Trombetta A, Dentelli P, Rosso A, Brizzi MF.
Diabetologia. 2011 Jul;54(7):1930-40.
Improving murine embryonic stem cell differentiation into cardiomyocytes with neuregulin-1: differential expression of microRNA.
Sun M, Yan X, Bian Y, Caggiano AO, Morgan JP.
Am J Physiol Cell Physiol. 2011 Jul;301(1):C21-30.
Paving new paths for neuregulin-1-assisted cardiac regenerative medicine. Focus on "Improving murine embryonic stem cell differentiation
into cardiomyocytes with neuregulin-1: differential expression of microRNA".
Lemmens K, De Keulenaer GW.
Am J Physiol Cell Physiol. 2011 Jul;301(1):C16-7.
Myocardial AKT: the omnipresent nexus.
Sussman MA, Völkers M, Fischer K, Bailey B, Cottage CT, Din S, Gude N, Avitabile D, Alvarez R, Sundararaman B, Quijada P, Mason M,
Konstandin MH, Malhowski A, Cheng Z, Khan M, McGregor M.
Physiol Rev. 2011 Jul;91(3):1023-70.
Differential expression of microRNAs in cardiac myocytes compared to undifferentiated P19 cells.
Hu DL, Liu YQ, Chen FK, Sheng YH, Yang R, Kong XQ, Cao KJ, Zhang JS, Qian LM.
Int J Mol Med. 2011 Jul;28(1):59-64.
Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning.
Semenza GL.
Biochim Biophys Acta. 2011 Jul;1813(7):1263-8.
Proteasomal degradation of myocardin is required for its transcriptional activity in vascular smooth muscle cells.
Yin H, Jiang Y, Li H, Li J, Gui Y, Zheng XL.
J Cell Physiol. 2011 Jul;226(7):1897-906.
Tinman/Nkx2-5 acts via miR-1 and upstream of Cdc42 to regulate heart function across species.
Qian L, Wythe JD, Liu J, Cartry J, Vogler G, Mohapatra B, Otway RT, Huang Y, King IN, Maillet M, Zheng Y, Crawley T, Taghli-Lamallem O,
Semsarian C, Dunwoodie S, Winlaw D, Harvey RP, Fatkin D, Towbin JA, Molkentin JD, Srivastava D, Ocorr K, Bruneau BG, Bodmer R.
J Cell Biol. 2011 Jun 27;193(7):1181-96.
miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors.
Crippa S, Cassano M, Messina G, Galli D, Galvez BG, Curk T, Altomare C, Ronzoni F, Toelen J, Gijsbers R, Debyser Z, Janssens S,
Zupan B, Zaza A, Cossu G, Sampaolesi M.
J Cell Biol. 2011 Jun 27;193(7):1197-212.
MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression.
Qin B, Xiao B, Liang D, Xia J, Li Y, Yang H.
Biochem Biophys Res Commun. 2011 Jun 24;410(1):127-33.
Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart.
Ahmed RP, Haider HK, Buccini S, Li L, Jiang S, Ashraf M.
Circ Res. 2011 Jun 24;109(1):60-70.
MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial
inflammation.
Zhou J, Wang KC, Wu W, Subramaniam S, Shyy JY, Chiu JJ, Li JY, Chien S.
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10355-60.
Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy.
Rau F, Freyermuth F, Fugier C, Villemin JP, Fischer MC, Jost B, Dembele D, Gourdon G, Nicole A, Duboc D, Wahbi K, Day JW, Fujimura
H, Takahashi MP, Auboeuf D, Dreumont N, Furling D, Charlet-Berguerand N.
Nat Struct Mol Biol. 2011 Jun 19;18(7):840-5.
MicroRNA expression signature in atrial fibrillation with mitral stenosis.
Xiao J, Liang D, Zhang Y, Liu Y, Zhang H, Liu Y, Li L, Liang X, Sun Y, Chen YH.
Physiol Genomics. 2011 Jun 15;43(11):655-64.
MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats.
Soci UP, Fernandes T, Hashimoto NY, Mota GF, Amadeu MA, Rosa KT, Irigoyen MC, Phillips MI, Oliveira EM.
Physiol Genomics. 2011 Jun 15;43(11):665-73.
Structural evidence of anti-atherogenic microRNAs.
Virtue A, Mai J, Yin Y, Meng S, Tran T, Jiang X, Wang H, Yang XF.
Front Biosci. 2011 Jun 1;17:3133-45.
MiR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II.
Xiao J, Zhu X, He B, Zhang Y, Kang B, Wang Z, Ni X.
J Biomed Sci. 2011 Jun 1;18:35.
Epigenetic mechanisms in diabetic vascular complications.
Reddy MA, Natarajan R.
Cardiovasc Res. 2011 Jun 1;90(3):421-9.
Non-coding RNAs as regulators of gene expression and epigenetics.
Kaikkonen MU, Lam MT, Glass CK.
Cardiovasc Res. 2011 Jun 1;90(3):430-40.
MicroRNAs in cardiometabolic disease.
Najafi-Shoushtari SH.
Curr Atheroscler Rep. 2011 Jun;13(3):202-7.
PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis.
Chinchilla A, Daimi H, Lozano-Velasco E, Dominguez JN, Caballero R, Delpón E, Tamargo J, Cinca J, Hove-Madsen L, Aranega AE,
Franco D.
Circ Cardiovasc Genet. 2011 Jun;4(3):269-79.
Elevated miR-499 levels blunt the cardiac stress response.
Shieh JT, Huang Y, Gilmore J, Srivastava D.
PLoS One. 2011 May 9;6(5):e19481.
Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury?
Albinsson S, Sessa WC.
Physiol Genomics. 2011 May 1;43(10):529-33.
Expression of microRNAs and their target mRNAs in human stem cell-derived cardiomyocyte clusters and in heart tissue.
Synnergren J, Améen C, Lindahl A, Olsson B, Sartipy P.
Physiol Genomics. 2011 May 1;43(10):581-94.
The role of microRNA in modulating myocardial ischemia-reperfusion injury.
Ye Y, Perez-Polo JR, Qian J, Birnbaum Y.
Physiol Genomics. 2011 May 1;43(10):534-42.
Normalization strategy is critical for the outcome of miRNA expression analyses in the rat heart.
Brattelid T, Aarnes EK, Helgeland E, Guvaåg S, Eichele H, Jonassen AK.
Physiol Genomics. 2011 May 1;43(10):604-10.
miR-193 expression differentiates telocytes from other stromal cells.
Cismasiu VB, Radu E, Popescu LM.
J Cell Mol Med. 2011 May;15(5):1071-4.
Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure.
Funahashi H, Izawa H, Hirashiki A, Cheng XW, Inden Y, Nomura M, Murohara T.
J Cardiol. 2011 May;57(3):338-44.
MicroRNAs in the cardiovascular system.
Han M, Toli J, Abdellatif M.
Curr Opin Cardiol. 2011 May;26(3):181-9.
Current world literature.
[No authors listed]
Curr Opin Cardiol. 2011 May;26(3):270-4.
A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in
contributing to thoracic aortic dissection pathogenesis.
Liao M, Zou S, Weng J, Hou L, Yang L, Zhao Z, Bao J, Jing Z.
J Vasc Surg. 2011 May;53(5):1341-1349.e3.
MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells.
Ni CW, Qiu H, Jo H.
Am J Physiol Heart Circ Physiol. 2011 May;300(5):H1762-9.
MicroRNAs and cardiovascular diseases.
Ono K, Kuwabara Y, Han J.
FEBS J. 2011 May;278(10):1619-33.
OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular
diseases.
Chen KC, Wang YS, Hu CY, Chang WC, Liao YC, Dai CY, Juo SH.
FASEB J. 2011 May;25(5):1718-28.
Smooth muscle miRNAs are critical for post-natal regulation of blood pressure and vascular function.
Albinsson S, Skoura A, Yu J, DiLorenzo A, Fernández-Hernando C, Offermanns S, Miano JM, Sessa WC.
PLoS One. 2011 Apr 22;6(4):e18869.
A genome-wide screen reveals a role for microRNA-1 in modulating cardiac cell polarity.
King IN, Qian L, Liang J, Huang Y, Shieh JT, Kwon C, Srivastava D.
Dev Cell. 2011 Apr 19;20(4):497-510.
MicroRNA let-7 establishes expression of beta2-adrenergic receptors and dynamically down-regulates agonist-promoted down-regulation.
Wang WC, Juan AH, Panebra A, Liggett SB.
Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6246-51.
[MicroRNA-144 over-expression induced myocytes apoptosis].
Huang F, Huang XY, Yan DS, Zhou X, Yang DY.
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Apr;39(4):353-7.
[Role of circulating microRNA on clinical diagnosis of cardiovascular diseases].
Nie Y, Liu Z, Chen X.
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Apr;39(4):377-82.
Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration.
Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, Guo Z, Liu J, Wang Y, Yuan W, Qin Y.
Atherosclerosis. 2011 Apr;215(2):286-93.
miR-143 and miR-145: Molecular keys to switch the phenotype of vascular smooth muscle cells.
Rangrez AY, Massy ZA, Metzinger-Le Meuth V, Metzinger L.
Circ Cardiovasc Genet. 2011 Apr;4(2):197-205.
MicroRNAs in lipid metabolism.
Fernández-Hernando C, Suárez Y, Rayner KJ, Moore KJ.
Curr Opin Lipidol. 2011 Apr;22(2):86-92.
Unexpected pro-injury effect of propofol on vascular smooth muscle cells with increased oxidative stress.
Wang X, Cheng Y, Liu X, Yang J, Munoz D, Zhang C.
Crit Care Med. 2011 Apr;39(4):738-45.
Molecular regulation of endothelial cell activation: novel mechanisms and emerging targets.
Charreau B.
Curr Opin Organ Transplant. 2011 Apr;16(2):207-13.
MicroRNAs in cardiac disease.
Dorn GW 2nd.
Transl Res. 2011 Apr;157(4):226-35.
MicroRNA-26a is a novel regulator of vascular smooth muscle cell function.
Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L, Kundu RK, Quertermous T, Tsao PS, Spin JM.
J Cell Physiol. 2011 Apr;226(4):1035-43.
Human cardiac stem cell differentiation is regulated by a mircrine mechanism.
Hosoda T, Zheng H, Cabral-da-Silva M, Sanada F, Ide-Iwata N, Ogórek B, Ferreira-Martins J, Arranto C, D'Amario D, del Monte F,
Urbanek K, D'Alessandro DA, Michler RE, Anversa P, Rota M, Kajstura J, Leri A.
Circulation. 2011 Mar 29;123(12):1287-96.
MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4.
Yang K, He YS, Wang XQ, Lu L, Chen QJ, Liu J, Sun Z, Shen WF.
FEBS Lett. 2011 Mar 23;585(6):854-60.
Role of miR-1 and miR-133a in myocardial ischemic postconditioning.
He B, Xiao J, Ren AJ, Zhang YF, Zhang H, Chen M, Xie B, Gao XG, Wang YW.
J Biomed Sci. 2011 Mar 16;18:22.
Novel mechanism of the vascular protector prostacyclin: regulating microRNA expression.
Mohite A, Chillar A, So SP, Cervantes V, Ruan KH.
Biochemistry. 2011 Mar 15;50(10):1691-9.
Role for miR-204 in human pulmonary arterial hypertension.
Courboulin A, Paulin R, Giguère NJ, Saksouk N, Perreault T, Meloche J, Paquet ER, Biardel S, Provencher S, Côté J, Simard MJ, Bonnet
S.
J Exp Med. 2011 Mar 14;208(3):535-48.
miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes.
Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D.
J Exp Med. 2011 Mar 14;208(3):549-60.
MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle
cells.
Grundmann S, Hans FP, Kinniry S, Heinke J, Helbing T, Bluhm F, Sluijter JP, Hoefer I, Pasterkamp G, Bode C, Moser M.
Circulation. 2011 Mar 8;123(9):999-1009.
Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus.
Bommer GT, MacDougald OA.
Cell Metab. 2011 Mar 2;13(3):241-7.
MicroRNAs and atrial fibrillation: new fundamentals.
Wang Z, Lu Y, Yang B.
Cardiovasc Res. 2011 Mar 1;89(4):710-21.
New insights into the molecular basis of atrial fibrillation: mechanistic and therapeutic implications.
Dobrev D, Nattel S.
Cardiovasc Res. 2011 Mar 1;89(4):689-91.
MicroRNAs in cardiomyocyte development.
Malizia AP, Wang DZ.
Wiley Interdiscip Rev Syst Biol Med. 2011 Mar-Apr;3(2):183-90.
Cardioprotective microRNAs.
Abdellatif M.
Pediatr Cardiol. 2011 Mar;32(3):311-6.
Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS.
Yu ML, Wang JF, Wang GK, You XH, Zhao XX, Jing Q, Qin YW.
Circ J. 2011 Mar;75(3):703-9.
Potential role of maternal serum microRNAs as a biomarker for fetal congenital heart defects.
Yu Z, Han S, Hu P, Zhu C, Wang X, Qian L, Guo X.
Med Hypotheses. 2011 Mar;76(3):424-6.
MicroRNA expression analysis: clinical advantage of propranolol reveals key microRNAs in myocardial infarction.
Zhu W, Yang L, Shan H, Zhang Y, Zhou R, Su Z, Du Z.
PLoS One. 2011 Feb 28;6(2):e14736.
miRNAs got rhythm.
Elton TS, Martin MM, Sansom SE, Belevych AE, Györke S, Terentyev D.
Life Sci. 2011 Feb 28;88(9-10):373-83.
Clinical, molecular, and genomic changes in response to a left ventricular assist device.
Hall JL, Fermin DR, Birks EJ, Barton PJ, Slaughter M, Eckman P, Baba HA, Wohlschlaeger J, Miller LW.
J Am Coll Cardiol. 2011 Feb 8;57(6):641-52.
Regulation of cardiac microRNAs by serum response factor.
Zhang X, Azhar G, Helms SA, Wei JY.
J Biomed Sci. 2011 Feb 8;18:15.
Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7.
Yang Y, Ago T, Zhai P, Abdellatif M, Sadoshima J.
Circ Res. 2011 Feb 4;108(3):305-13.
Restriction of big hearts by a small RNA.
Sun H, Wang Y.
Circ Res. 2011 Feb 4;108(3):274-6.
Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease.
Zhang Q, Kandic I, Kutryk MJ.
Biochem Biophys Res Commun. 2011 Feb 4;405(1):42-6.
Letter by van Mil et al regarding, "Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells:
role for miR-499".
van Mil A, Doevendans PA, Sluijter JP.
Circ Cardiovasc Genet. 2011 Feb 1;4(1):e3
Letter by D'Alessandra et al regarding article, "Circulating microRNA-208b and microRNA-499 reflect myocardial damage in
cardiovascular disease".
D'Alessandra Y, Pompilio G, Capogrossi MC.
Circ Cardiovasc Genet. 2011 Feb 1;4(1):e7
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart.
Creemers EE, Pinto YM.
Cardiovasc Res. 2011 Feb 1;89(2):265-72.
Comparison of different miR-21 inhibitor chemistries in a cardiac disease model.
Thum T, Chau N, Bhat B, Gupta SK, Linsley PS, Bauersachs J, Engelhardt S.
J Clin Invest. 2011 Feb 1;121(2):461-2
The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs.
Schlesinger J, Schueler M, Grunert M, Fischer JJ, Zhang Q, Krueger T, Lange M, Tönjes M, Dunkel I, Sperling SR.
PLoS Genet. 2011 Feb;7(2):e1001313.
microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors.
Geisler A, Jungmann A, Kurreck J, Poller W, Katus HA, Vetter R, Fechner H, Müller OJ.
Gene Ther. 2011 Feb;18(2):199-209.
Assessment of plasma miRNAs in congestive heart failure.
Fukushima Y, Nakanishi M, Nonogi H, Goto Y, Iwai N.
Circ J. 2011 Feb;75(2):336-40.
MicroRNA, emerging role as a biomarker of heart failure.
Kawashima T, Shioi T.
Circ J. 2011 Feb;75(2):268-9.
microRNAs in hypertrophy and heart failure.
Latronico MV, Condorelli G.
Exp Biol Med (Maywood). 2011 Feb;236(2):125-31.
ST depression, arrhythmia, vagal dominance, and reduced cardiac micro-RNA in particulate-exposed rats.
Farraj AK, Hazari MS, Haykal-Coates N, Lamb C, Winsett DW, Ge Y, Ledbetter AD, Carll AP, Bruno M, Ghio A, Costa DL.
Am J Respir Cell Mol Biol. 2011 Feb;44(2):185-96.
Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation.
Chen J, Yin H, Jiang Y, Radhakrishnan SK, Huang ZP, Li J, Shi Z, Kilsdonk EP, Gui Y, Wang DZ, Zheng XL.
Arterioscler Thromb Vasc Biol. 2011 Feb;31(2):368-75.
MicroRNA-27a regulates beta cardiac myosin heavy chain gene expression by targeting thyroid hormone receptor beta1 in neonatal rat
ventricular myocytes.
Nishi H, Ono K, Horie T, Nagao K, Kinoshita M, Kuwabara Y, Watanabe S, Takaya T, Tamaki Y, Takanabe-Mori R, Wada H, Hasegawa K,
Iwanaga Y, Kawamura T, Kita T, Kimura T.
Mol Cell Biol. 2011 Feb;31(4):744-55.
MicroRNAs differentially expressed in postnatal aortic development downregulate elastin via 3' UTR and coding-sequence binding sites.
Ott CE, Grünhagen J, Jäger M, Horbelt D, Schwill S, Kallenbach K, Guo G, Manke T, Knaus P, Mundlos S, Robinson PN.
PLoS One. 2011 Jan 31;6(1):e16250.
Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2.
Smits M, Mir SE, Nilsson RJ, van der Stoop PM, Niers JM, Marquez VE, Cloos J, Breakefield XO, Krichevsky AM, Noske DP, Tannous
BA, Würdinger T.
PLoS One. 2011 Jan 28;6(1):e16282.
Microribonucleic acids for prevention of plaque rupture and in-stent restenosis: "a finger in the dam".
O'Sullivan JF, Martin K, Caplice NM.
J Am Coll Cardiol. 2011 Jan 25;57(4):383-9.
Two functional microRNA-126s repress a novel target gene p21-activated kinase 1 to regulate vascular integrity in zebrafish.
Zou J, Li WQ, Li Q, Li XQ, Zhang JT, Liu GQ, Chen J, Qiu XX, Tian FJ, Wang ZZ, Zhu N, Qin YW, Shen B, Liu TX, Jing Q.
Circ Res. 2011 Jan 21;108(2):201-9.
Pervasive roles of microRNAs in cardiovascular biology.
Small EM, Olson EN.
Nature. 2011 Jan 20;469(7330):336-42.
Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans.
Li T, Cao H, Zhuang J, Wan J, Guan M, Yu B, Li X, Zhang W.
Clin Chim Acta. 2011 Jan 14;412(1-2):66-70.
"RISCing" the heart: In vivo identification of cardiac microRNA targets by RISCome.
Ding J, Wang DZ.
Circ Res. 2011 Jan 7;108(1):3-5.
MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression.
Chinchilla A, Lozano E, Daimi H, Esteban FJ, Crist C, Aranega AE, Franco D.
Cardiovasc Res. 2011 Jan 1;89(1):98-108.
Heartbeat regulates cardiogenesis by suppressing retinoic acid signaling via expression of miR-143.
Miyasaka KY, Kida YS, Banjo T, Ueki Y, Nagayama K, Matsumoto T, Sato M, Ogura T.
Mech Dev. 2011 Jan-Feb;128(1-2):18-28.
Contemporary approaches to genetic influences on hypertension.
Fung MM, Zhang K, Zhang L, Rao F, O'Connor DT.
Curr Opin Nephrol Hypertens. 2011 Jan;20(1):23-30.
MicroRNAs in vascular disease.
Qin S, Zhang C.
J Cardiovasc Pharmacol. 2011 Jan;57(1):8-12.
[Resveratrol acts by modulating miRNAs].
Latruffe N.
Med Sci (Paris). 2011 Jan;27(1):31-3.
MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction.
Meder B, Keller A, Vogel B, Haas J, Sedaghat-Hamedani F, Kayvanpour E, Just S, Borries A, Rudloff J, Leidinger P, Meese E, Katus HA,
Rottbauer W.
Basic Res Cardiol. 2011 Jan;106(1):13-23.
Control of cardiovascular differentiation by microRNAs.
Ohtani K, Dimmeler S.
Basic Res Cardiol. 2011 Jan;106(1):5-11.
Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re(generation).
Kane NM, Xiao Q, Baker AH, Luo Z, Xu Q, Emanueli C.
Pharmacol Ther. 2011 Jan;129(1):29-49.
miRNAs: roles and clinical applications in vascular disease.
Jamaluddin MS, Weakley SM, Zhang L, Kougias P, Lin PH, Yao Q, Chen C.
Expert Rev Mol Diagn. 2011 Jan;11(1):79-89.
miR-146a and Krüppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation.
Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB, Su M, Han Y, Shi HJ, Wen JK.
EMBO Rep. 2011 Jan;12(1):56-62.
MicroRNA signatures of resveratrol in the ischemic heart.
Mukhopadhyay P, Pacher P, Das DK.
Ann N Y Acad Sci. 2011 Jan;1215:109-16.
miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1.
Wang JX, Jiao JQ, Li Q, Long B, Wang K, Liu JP, Li YR, Li PF.
Nat Med. 2011 Jan;17(1):71-8.
[The role of micro-RNA/143/145 in evolution of intra-stent restenosis].
Popovich IM.
Kardiologiia. 2011;51(9):17-21.
Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are
selectively dependent on renal elimination, and can be detected in urine samples.
Gidlöf O, Andersson P, van der Pals J, Götberg M, Erlinge D.
Cardiology. 2011;118(4):217-26.
Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory
modules.
Park JY, Li W, Zheng D, Zhai P, Zhao Y, Matsuda T, Vatner SF, Sadoshima J, Tian B.
PLoS One. 2011;6(7):e22391.
Targeted delivery of mutant tolerant anti-coxsackievirus artificial microRNAs using folate conjugated bacteriophage Phi29 pRNA.
Ye X, Liu Z, Hemida MG, Yang D.
PLoS One. 2011;6(6):e21215.
Identification of MicroRNAs involved in hypoxia- and serum deprivation-induced apoptosis in mesenchymal stem cells.
Nie Y, Han BM, Liu XB, Yang JJ, Wang F, Cong XF, Chen X.
Int J Biol Sci. 2011;7(6):762-8.
HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3.
Limana F, Esposito G, D'Arcangelo D, Di Carlo A, Romani S, Melillo G, Mangoni A, Bertolami C, Pompilio G, Germani A, Capogrossi MC.
PLoS One. 2011;6(6):e19845.
The role of blood flow and microRNAs in blood vessel development.
Liu D, Krueger J, Le Noble F.
Int J Dev Biol. 2011;55(4-5):419-29.
Whole genome network analysis of ion channels and connexins in myocardial infarction.
Zhou R, Hang P, Zhu W, Su Z, Liang H, Du Z.
Cell Physiol Biochem. 2011;27(3-4):299-304.
Restoration of altered microRNA expression in the ischemic heart with resveratrol.
Mukhopadhyay P, Mukherjee S, Ahsan K, Bagchi A, Pacher P, Das DK.
PLoS One. 2010 Dec 23;5(12):e15705.
Bmp signaling regulates myocardial differentiation from cardiac progenitors through a MicroRNA-mediated mechanism.
Wang J, Greene SB, Bonilla-Claudio M, Tao Y, Zhang J, Bai Y, Huang Z, Black BL, Wang F, Martin JF.
Dev Cell. 2010 Dec 14;19(6):903-12.
Common microRNA signatures in cardiac hypertrophic and atrophic remodeling induced by changes in hemodynamic load.
El-Armouche A, Schwoerer AP, Neuber C, Emmons J, Biermann D, Christalla T, Grundhoff A, Eschenhagen T, Zimmermann WH, Ehmke
H.
PLoS One. 2010 Dec 9;5(12):e14263.
MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation.
Lu Y, Zhang Y, Wang N, Pan Z, Gao X, Zhang F, Zhang Y, Shan H, Luo X, Bai Y, Sun L, Song W, Xu C, Wang Z, Yang B.
Circulation. 2010 Dec 7;122(23):2378-87.
Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease.
Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B.
Circ Cardiovasc Genet. 2010 Dec 1;3(6):499-506.
MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1
macrophages.
Huang RS, Hu GQ, Lin B, Lin ZY, Sun CC.
J Investig Med. 2010 Dec;58(8):961-7.
Highlights from the 2010 BAS/BSCR spring meeting: New Frontiers in Cardiovascular Research.
Abonnenc M, Stegemann C, Mayr M.
Expert Rev Proteomics. 2010 Dec;7(6):811-3.
microRNAs and cholesterol metabolism.
Moore KJ, Rayner KJ, Suárez Y, Fernández-Hernando C.
Trends Endocrinol Metab. 2010 Dec;21(12):699-706.
MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.
da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, el Azzouzi H, Hansen A, Coenen-de Roo CJ, Bierhuizen MF, van der
Nagel R, van Kuik J, de Weger R, de Bruin A, Condorelli G, Arbones ML, Eschenhagen T, De Windt LJ.
Nat Cell Biol. 2010 Dec;12(12):1220-7.
Loss of microRNAs in neural crest leads to cardiovascular syndromes resembling human congenital heart defects.
Huang ZP, Chen JF, Regan JN, Maguire CT, Tang RH, Dong XR, Majesky MW, Wang DZ.
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2575-86.
MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling.
Small EM, Sutherland LB, Rajagopalan KN, Wang S, Olson EN.
Circ Res. 2010 Nov 26;107(11):1336-44.
VEGF signaling has distinct spatiotemporal roles during heart valve development.
Stankunas K, Ma GK, Kuhnert FJ, Kuo CJ, Chang CP.
Dev Biol. 2010 Nov 15;347(2):325-36.
Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseases.
Shi MA, Shi GP.
Sci Signal. 2010 Nov 2;3(146):pe40.
The cellular response to hypoxia: tuning the system with microRNAs.
Loscalzo J.
J Clin Invest. 2010 Nov 1;120(11):3815-7.
Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-α isoforms and promotes angiogenesis.
Ghosh G, Subramanian IV, Adhikari N, Zhang X, Joshi HP, Basi D, Chandrashekhar YS, Hall JL, Roy S, Zeng Y, Ramakrishnan S.
J Clin Invest. 2010 Nov 1;120(11):4141-54.
Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice.
Patrick DM, Montgomery RL, Qi X, Obad S, Kauppinen S, Hill JA, van Rooij E, Olson EN.
J Clin Invest. 2010 Nov 1;120(11):3912-6.
The magic and mystery of miR-21.
Morrisey EE.
J Clin Invest. 2010 Nov 1;120(11):3817-9.
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction.
D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, Micheli
B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G, Capogrossi MC.
Eur Heart J. 2010 Nov;31(22):2765-73.
The role of microRNA in cardiac excitability.
Wang Z.
J Cardiovasc Pharmacol. 2010 Nov;56(5):460-70.
Regulation of myocardial fibrosis by MicroRNAs.
Bauersachs J.
J Cardiovasc Pharmacol. 2010 Nov;56(5):454-9.
Role of microRNAs in cardiovascular disease: therapeutic challenges and potentials.
Port JD, Sucharov C.
J Cardiovasc Pharmacol. 2010 Nov;56(5):444-53.
MicroRNA: redefining mechanisms in cardiovascular diseases.
Abdellatif M.
J Cardiovasc Pharmacol. 2010 Nov;56(5):441-3.
Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced
cardiomyocyte death.
Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu WT, Jegga AG, Fan GC.
J Mol Cell Cardiol. 2010 Nov;49(5):841-50.
Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene
expression by targeting the histone methyltransferase Suv39h1.
Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L, Natarajan R.
Diabetes. 2010 Nov;59(11):2904-15.
MicroRNAs are dynamically regulated in hypertrophic hearts, and miR-199a is essential for the maintenance of cell size in cardiomyocytes.
Song XW, Li Q, Lin L, Wang XC, Li DF, Wang GK, Ren AJ, Wang YR, Qin YW, Yuan WJ, Jing Q.
J Cell Physiol. 2010 Nov;225(2):437-43.
MicroRNA-1 inhibits myocardin-induced contractility of human vascular smooth muscle cells.
Jiang Y, Yin H, Zheng XL.
J Cell Physiol. 2010 Nov;225(2):506-11.
Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation.
Gerin I, Clerbaux LA, Haumont O, Lanthier N, Das AK, Burant CF, Leclercq IA, MacDougald OA, Bommer GT.
J Biol Chem. 2010 Oct 29;285(44):33652-61.
Franklin H. Epstein Lecture. Cardiac development and implications for heart disease.
Epstein JA.
N Engl J Med. 2010 Oct 21;363(17):1638-47.
Increased transient receptor potential vanilloid type 1 (TRPV1) channel expression in hypertrophic heart.
Thilo F, Liu Y, Schulz N, Gergs U, Neumann J, Loddenkemper C, Gollasch M, Tepel M.
Biochem Biophys Res Commun. 2010 Oct 8;401(1):98-103.
MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo.
Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y, Hasegawa K, Yokode M,
Kimura T, Kita T.
Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17321-6.
Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499.
Wilson KD, Hu S, Venkatasubrahmanyam S, Fu JD, Sun N, Abilez OJ, Baugh JJ, Jia F, Ghosh Z, Li RA, Butte AJ, Wu JC.
Circ Cardiovasc Genet. 2010 Oct 1;3(5):426-35.
Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease.
Gupta SK, Bang C, Thum T.
Circ Cardiovasc Genet. 2010 Oct 1;3(5):484-8.
MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts.
Haider KH, Idris NM, Kim HW, Ahmed RP, Shujia J, Ashraf M.
Cardiovasc Res. 2010 Oct 1;88(1):168-78.
MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts.
Zheng L, Xu CC, Chen WD, Shen WL, Ruan CC, Zhu LM, Zhu DL, Gao PJ.
Biochem Biophys Res Commun. 2010 Oct 1;400(4):483-8.
MicroRNA-33: nature's own RNAi controls cholesterol homeostasis.
Gelissen IC, Jessup W.
Curr Opin Lipidol. 2010 Oct;21(5):464-5.
Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells.
Harris TA, Yamakuchi M, Kondo M, Oettgen P, Lowenstein CJ.
Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1990-7.
Prox1 expression is negatively regulated by miR-181 in endothelial cells.
Kazenwadel J, Michael MZ, Harvey NL.
Blood. 2010 Sep 30;116(13):2395-401.
MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury.
Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, Fan GC.
Circulation. 2010 Sep 28;122(13):1308-18.
MicroRNA-210 as a novel therapy for treatment of ischemic heart disease.
Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, Fasanaro P, Sun N, Wang X, Martelli F, Robbins RC, Wu JC.
Circulation. 2010 Sep 14;122(11 Suppl):S124-31.
Differential cardiac remodeling in preload versus afterload.
Toischer K, Rokita AG, Unsöld B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta
SN, Schmidt K, Lehnart SE, Krüger M, Linke WA, Backs J, Regitz-Zagrosek V, Schäfer K, Field LJ, Maier LS, Hasenfuss G.
Circulation. 2010 Sep 7;122(10):993-1003.
Circulating microRNAs in patients with coronary artery disease.
Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, Bonauer A,
Zeiher AM, Dimmeler S.
Circ Res. 2010 Sep 3;107(5):677-84.
Circulating microRNAs as potential biomarkers of coronary artery disease: a promise to be fulfilled?
Contu R, Latronico MV, Condorelli G.
Circ Res. 2010 Sep 3;107(5):573-4.
Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway.
Horie T, Ono K, Nishi H, Nagao K, Kinoshita M, Watanabe S, Kuwabara Y, Nakashima Y, Takanabe-Mori R, Nishi E, Hasegawa K, Kita T,
Kimura T.
Cardiovasc Res. 2010 Sep 1;87(4):656-64.
Epigenetics and cardiovascular disease.
Ordovás JM, Smith CE.
Nat Rev Cardiol. 2010 Sep;7(9):510-9.
Computational analysis of microRNA function in heart development.
Liu G, Ding M, Chen J, Huang J, Wang H, Jing Q, Shen B.
Acta Biochim Biophys Sin (Shanghai). 2010 Sep;42(9):662-70.
Novel regulators and drug targets of cardiac hypertrophy.
Finckenberg P, Mervaala E.
J Hypertens. 2010 Sep;28 Suppl 1:S33-8.
miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes.
Shan ZX, Lin QX, Deng CY, Zhu JN, Mai LP, Liu JL, Fu YH, Liu XY, Li YX, Zhang YY, Lin SG, Yu XY.
FEBS Lett. 2010 Aug 20;584(16):3592-600.
MicroRNA-34a regulation of endothelial senescence.
Ito T, Yagi S, Yamakuchi M.
Biochem Biophys Res Commun. 2010 Aug 6;398(4):735-40.
Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion
injury.
Ye Y, Hu Z, Lin Y, Zhang C, Perez-Polo JR.
Cardiovasc Res. 2010 Aug 1;87(3):535-44.
Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target
PDCD4.
Cheng Y, Zhu P, Yang J, Liu X, Dong S, Wang X, Chun B, Zhuang J, Zhang C.
Cardiovasc Res. 2010 Aug 1;87(3):431-9.
miR-21: a miRaculous Socratic paradox.
da Costa Martins PA, De Windt LJ.
Cardiovasc Res. 2010 Aug 1;87(3):397-400.
[miRNA changes in the reverse remodeling heart of rats].
Wang J, Zheng Z, Lin FQ, Sun CC, Xu RX, Hu SS.
Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Aug;38(8):745-50.
MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients.
Voellenkle C, van Rooij J, Cappuzzello C, Greco S, Arcelli D, Di Vito L, Melillo G, Rigolini R, Costa E, Crea F, Capogrossi MC, Napolitano
M, Martelli F.
Physiol Genomics. 2010 Aug;42(3):420-6.
MicroRNA-125a/b-5p inhibits endothelin-1 expression in vascular endothelial cells.
Li D, Yang P, Xiong Q, Song X, Yang X, Liu L, Yuan W, Rui YC.
J Hypertens. 2010 Aug;28(8):1646-54.
A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes.
Song KH, Li T, Owsley E, Chiang JY.
J Lipid Res. 2010 Aug;51(8):2223-33.
MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease.
Townley-Tilson WH, Callis TE, Wang D.
Int J Biochem Cell Biol. 2010 Aug;42(8):1252-5.
MicroRNAs in arterial remodelling, inflammation and atherosclerosis.
Weber C, Schober A, Zernecke A.
Curr Drug Targets. 2010 Aug;11(8):950-6.
Expression and function of microRNAs in heart disease.
Ikeda S, Pu WT.
Curr Drug Targets. 2010 Aug;11(8):913-25.
MicroRNA regulation in cardiovascular disease.
da Costa Martins PA, Leptidis S, Salic K, De Windt LJ.
Curr Drug Targets. 2010 Aug;11(8):900-6.
MicroRNA regulation as a therapeutic strategy for cardiovascular disease.
Montgomery RL, van Rooij E.
Curr Drug Targets. 2010 Aug;11(8):936-42.
Vascular microRNAs.
Bonauer A, Boon RA, Dimmeler S.
Curr Drug Targets. 2010 Aug;11(8):943-9.
MicroRNAs and cardiac conduction.
Latronico MV, Condorelli G.
Curr Drug Targets. 2010 Aug;11(8):907-12.
microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression.
Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, Brizzi MF.
Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1562-8.
Microregulation of plaque neovascularization.
Suárez Y.
Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1500-1.
MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro.
Fang Y, Shi C, Manduchi E, Civelek M, Davies PF.
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13450-5.
Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system
blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels.
Takahashi Y, Satoh M, Minami Y, Tabuchi T, Itoh T, Nakamura M.
Clin Sci (Lond). 2010 Jul 23;119(9):395-405.
Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy.
Li Q, Song XW, Zou J, Wang GK, Kremneva E, Li XQ, Zhu N, Sun T, Lappalainen P, Yuan WJ, Qin YW, Jing Q.
J Cell Sci. 2010 Jul 15;123(Pt 14):2444-52.
Gene expression profiling in whole blood of patients with coronary artery disease.
Taurino C, Miller WH, McBride MW, McClure JD, Khanin R, Moreno MU, Dymott JA, Delles C, Dominiczak AF.
Clin Sci (Lond). 2010 Jul 9;119(8):335-43.
Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease
through a microRNA-21-dependent mechanism.
Fleissner F, Jazbutyte V, Fiedler J, Gupta SK, Yin X, Xu Q, Galuppo P, Kneitz S, Mayr M, Ertl G, Bauersachs J, Thum T.
Circ Res. 2010 Jul 9;107(1):138-43.
A miR-thless perspective: how asymmetric dimethylarginine impairs the functions of angiogenic progenitor cells.
Brandes RP.
Circ Res. 2010 Jul 9;107(1):12-4.
miR-33 links SREBP-2 induction to repression of sterol transporters.
Marquart TJ, Allen RM, Ory DS, Baldán A.
Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12228-32.
MicroRNAs target gene and signaling pathway by bioinformatics analysis in the cardiac hypertrophy.
Shen E, Diao X, Wei C, Wu Z, Zhang L, Hu B.
Biochem Biophys Res Commun. 2010 Jul 2;397(3):380-5.
Altered microRNAs in bicuspid aortic valve: a comparison between stenotic and insufficient valves.
Nigam V, Sievers HH, Jensen BC, Sier HA, Simpson PC, Srivastava D, Mohamed SA.
J Heart Valve Dis. 2010 Jul;19(4):459-65.
miR-146a in PBMCs modulates Th1 function in patients with acute coronary syndrome.
Guo M, Mao X, Ji Q, Lang M, Li S, Peng Y, Zhou W, Xiong B, Zeng Q.
Immunol Cell Biol. 2010 Jul;88(5):555-64.
MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA.
Mishra PK, Metreveli N, Tyagi SC.
Cell Biochem Biophys. 2010 Jul;57(2-3):67-76.
MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator
1.
Zhao T, Li J, Chen AF.
Am J Physiol Endocrinol Metab. 2010 Jul;299(1):E110-6.
Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro
and in vivo.
Kane NM, Meloni M, Spencer HL, Craig MA, Strehl R, Milligan G, Houslay MD, Mountford JC, Emanueli C, Baker AH.
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1389-97.
Plasma microRNA 499 as a biomarker of acute myocardial infarction.
Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y, Nonogi H, Iwai N.
Clin Chem. 2010 Jul;56(7):1183-5.
An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p.
Rane S, He M, Sayed D, Yan L, Vatner D, Abdellatif M.
Cell Signal. 2010 Jul;22(7):1054-62.
MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.
Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Näär AM.
Science. 2010 Jun 18;328(5985):1566-9.
MiR-33 contributes to the regulation of cholesterol homeostasis.
Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernández-Hernando C.
Science. 2010 Jun 18;328(5985):1570-3.
Medicine. HDL miR-ed down by SREBP introns.
Brown MS, Ye J, Goldstein JL.
Science. 2010 Jun 18;328(5985):1495-6.
MicroRNA profiling in early hypertrophic growth of the left ventricle in rats.
Busk PK, Cirera S.
Biochem Biophys Res Commun. 2010 Jun 11;396(4):989-93.
Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells.
Doebele C, Bonauer A, Fischer A, Scholz A, Reiss Y, Urbich C, Hofmann WK, Zeiher AM, Dimmeler S.
Blood. 2010 Jun 10;115(23):4944-50.
MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism.
Lu H, Buchan RJ, Cook SA.
Cardiovasc Res. 2010 Jun 1;86(3):410-20.
Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure.
Poller W, Hajjar R, Schultheiss HP, Fechner H.
Cardiovasc Res. 2010 Jun 1;86(3):353-64.
Epigenetics in atherosclerosis and inflammation.
Wierda RJ, Geutskens SB, Jukema JW, Quax PH, van den Elsen PJ.
J Cell Mol Med. 2010 Jun;14(6A):1225-40.
Pharmacoepigenetics in heart failure.
Mateo Leach I, van der Harst P, de Boer RA.
Curr Heart Fail Rep. 2010 Jun;7(2):83-90.
MicroRNA expression and function in cardiac ischemic injury.
Yu S, Li G.
J Cardiovasc Transl Res. 2010 Jun;3(3):241-5.
Role of specific microRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury.
Song Z, Li G.
J Cardiovasc Transl Res. 2010 Jun;3(3):246-50.
MicroRNAs in cardiac remodeling and disease.
Huang ZP, Neppl RL, Wang DZ.
J Cardiovasc Transl Res. 2010 Jun;3(3):212-8.
MicroRNAs in cardiac apoptosis.
Li P.
J Cardiovasc Transl Res. 2010 Jun;3(3):219-24.
MicroRNAs--regulators of signaling networks in dilated cardiomyopathy.
Naga Prasad SV, Karnik SS.
J Cardiovasc Transl Res. 2010 Jun;3(3):225-34.
MicroRNAs in vascular biology and vascular disease.
Zhang C.
J Cardiovasc Transl Res. 2010 Jun;3(3):235-40.
MicroRNA-21 in cardiovascular disease.
Cheng Y, Zhang C.
J Cardiovasc Transl Res. 2010 Jun;3(3):251-5.
MicroRNAs in cardiovascular diseases: biology and potential clinical applications.
Kartha RV, Subramanian S.
J Cardiovasc Transl Res. 2010 Jun;3(3):256-70.
MicroRNAs and ultraconserved genes as diagnostic markers and therapeutic targets in cancer and cardiovascular diseases.
Edwards JK, Pasqualini R, Arap W, Calin GA.
J Cardiovasc Transl Res. 2010 Jun;3(3):271-9.
miRNAs as therapeutic targets in ischemic heart disease.
Frost RJ, van Rooij E.
J Cardiovasc Transl Res. 2010 Jun;3(3):280-9.
Human DNA methyltransferase 3a does not associate with microRNAs in the regulation of DNA methylation.
Park CW, Zeng Y, Steer CJ.
J Cardiovasc Transl Res. 2010 Jun;3(3):290-5.
The emerging role of microRNAs as a therapeutic target for cardiovascular disease.
Seok HY, Wang DZ.
BioDrugs. 2010 Jun;24(3):147-55.
MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function.
Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC.
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1118-26.
The miR-143-adducin3 pathway is essential for cardiac chamber morphogenesis.
Deacon DC, Nevis KR, Cashman TJ, Zhou Y, Zhao L, Washko D, Guner-Ataman B, Burns CG, Burns CE.
Development. 2010 Jun;137(11):1887-96.
Bioinformatic identification and characterization of human endothelial cell-restricted genes.
Bhasin M, Yuan L, Keskin DB, Otu HH, Libermann TA, Oettgen P.
BMC Genomics. 2010 May 28;11:342.
MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p.
Kumarswamy R, Thum T, Anker SD.
Circ Res. 2010 May 14;106(9):e8
Therapeutic potential of microRNAs in heart failure.
Dorn GW 2nd.
Curr Cardiol Rep. 2010 May;12(3):209-15.
Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy.
Satoh M, Minami Y, Takahashi Y, Tabuchi T, Nakamura M.
J Card Fail. 2010 May;16(5):404-10.
Effect of maternal undernutrition on vascular expression of micro and messenger RNA in newborn and aging offspring.
Khorram O, Han G, Bagherpour R, Magee TR, Desai M, Ross MG, Chaudhri AA, Toloubeydokhti T, Pearce WJ.
Am J Physiol Regul Integr Comp Physiol. 2010 May;298(5):R1366-74.
[Role of heat shock proteins, aldose reductase, Bcl-2 protein and microRNA in the mechanism of delayed preconditioning of heart]
Lishmanov IuB, Maslov LN, Khaliulin IG, Zhang Y, Pei JM.
Ross Fiziol Zh Im I M Sechenova. 2010 May;96(5):472-88.
NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression.
Li Q, Lin X, Yang X, Chang J.
Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1340-7.
MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis.
Nicoli S, Standley C, Walker P, Hurlstone A, Fogarty KE, Lawson ND.
Nature. 2010 Apr 22;464(7292):1196-200.
Identification of responsive gene modules by network-based gene clustering and extending: application to inflammation and angiogenesis.
Gu J, Chen Y, Li S, Li Y.
BMC Syst Biol. 2010 Apr 21;4:47.
A translational study of circulating cell-free microRNA-1 in acute myocardial infarction.
Cheng Y, Tan N, Yang J, Liu X, Cao X, He P, Dong X, Qin S, Zhang C.
Clin Sci (Lond). 2010 Apr 20;119(2):87-95.
MicroRNA regulatory networks in cardiovascular development.
Liu N, Olson EN.
Dev Cell. 2010 Apr 20;18(4):510-25.
miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy.
Wang K, Long B, Zhou J, Li PF.
J Biol Chem. 2010 Apr 16;285(16):11903-12.
The peripheral blood mononuclear cell microRNA signature of coronary artery disease.
Hoekstra M, van der Lans CA, Halvorsen B, Gullestad L, Kuiper J, Aukrust P, van Berkel TJ, Biessen EA.
Biochem Biophys Res Commun. 2010 Apr 9;394(3):792-7.
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro.
Quintavalle M, Elia L, Condorelli G, Courtneidge SA.
J Cell Biol. 2010 Apr 5;189(1):13-22.
MiR423-5p as a circulating biomarker for heart failure.
Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM.
Circ Res. 2010 Apr 2;106(6):1035-9.
MicroRNAs and heart failure diagnosis: MiR-acle or MiR-age?
Markham DW, Hill JA.
Circ Res. 2010 Apr 2;106(6):1011-3.
MicroRNAs coordinate an alternative splicing network during mouse postnatal heart development.
Kalsotra A, Wang K, Li PF, Cooper TA.
Genes Dev. 2010 Apr 1;24(7):653-8.
MicroRNAs in cardiac development and remodeling.
Wang DZ.
Pediatr Cardiol. 2010 Apr;31(3):357-62.
MicroRNAs in cardiac development.
Cordes KR, Srivastava D, Ivey KN.
Pediatr Cardiol. 2010 Apr;31(3):349-56.
MicroRNAs in atherosclerosis and lipoprotein metabolism.
Vickers KC, Remaley AT.
Curr Opin Endocrinol Diabetes Obes. 2010 Apr;17(2):150-5.
MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells.
Sluijter JP, van Mil A, van Vliet P, Metz CH, Liu J, Doevendans PA, Goumans MJ.
Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):859-68.
PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.
Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, Speirs HJ,
Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du XJ, McMullen JR.
Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):724-32.
A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial
infarcted nonhuman primates.
Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B, Bellamy V, Rücker-Martin C, Barbry P, Bel A, Bruneval P, Cowan C, Pouly J,
Mitalipov S, Gouadon E, Binder P, Hagège A, Desnos M, Renaud JF, Menasché P, Pucéat M.
J Clin Invest. 2010 Apr;120(4):1125-39.
Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac
hypertrophy.
Dong DL, Chen C, Huo R, Wang N, Li Z, Tu YJ, Hu JT, Chu X, Huang W, Yang BF.
Hypertension. 2010 Apr;55(4):946-52.
Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes.
Liu Y, Taylor NE, Lu L, Usa K, Cowley AW Jr, Ferreri NR, Yeo NC, Liang M.
Hypertension. 2010 Apr;55(4):974-82.
MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity.
Weber M, Baker MB, Moore JP, Searles CD.
Biochem Biophys Res Commun. 2010 Mar 19;393(4):643-8.
MicroRNAs add a new dimension to cardiovascular disease.
Small EM, Frost RJ, Olson EN.
Circulation. 2010 Mar 2;121(8):1022-32.
Altered expression of microRNAs in the myocardium of rats with acute myocardial infarction.
Shi B, Guo Y, Wang J, Gao W.
BMC Cardiovasc Disord. 2010 Mar 1;10:11.
microRNAs in heart disease: putative novel therapeutic targets?
Condorelli G, Latronico MV, Dorn GW 2nd.
Eur Heart J. 2010 Mar;31(6):649-58.
Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans.
Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q.
Eur Heart J. 2010 Mar;31(6):659-66.
Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.
Fijalkowska I, Xu W, Comhair SA, Janocha AJ, Mavrakis LA, Krishnamachary B, Zhen L, Mao T, Richter A, Erzurum SC, Tuder RM.
Am J Pathol. 2010 Mar;176(3):1130-8.
MicroRNAs in angiogenesis and vascular smooth muscle cell function.
Daubman S.
Circ Res. 2010 Feb 19;106(3):423-5.
MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells.
Qin X, Wang X, Wang Y, Tang Z, Cui Q, Xi J, Li YS, Chien S, Wang N.
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3240-4.
Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth.
Wang KC, Garmire LX, Young A, Nguyen P, Trinh A, Subramaniam S, Wang N, Shyy JY, Li YS, Chien S.
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3234-9.
The year in heart failure.
Tang WH, Francis GS.
J Am Coll Cardiol. 2010 Feb 16;55(7):688-96.
MicroRNA-15b modulates cellular ATP levels and degenerates mitochondria via Arl2 in neonatal rat cardiac myocytes.
Nishi H, Ono K, Iwanaga Y, Horie T, Nagao K, Takemura G, Kinoshita M, Kuwabara Y, Mori RT, Hasegawa K, Kita T, Kimura T.
J Biol Chem. 2010 Feb 12;285(7):4920-30.
Roles for endoplasmic reticulum-associated degradation and the novel endoplasmic reticulum stress response gene Derlin-3 in the
ischemic heart.
Belmont PJ, Chen WJ, San Pedro MN, Thuerauf DJ, Gellings Lowe N, Gude N, Hilton B, Wolkowicz R, Sussman MA, Glembotski CC.
Circ Res. 2010 Feb 5;106(2):307-16.
The year's successes in failure: Circulation Research takes a look at the key research developments of 2009 that are providing hope in the
field of heart failure.
Williams R.
Circ Res. 2010 Feb 5;106(2):213-5.
Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression.
Chan MC, Hilyard AC, Wu C, Davis BN, Hill NS, Lal A, Lieberman J, Lagna G, Hata A.
EMBO J. 2010 Feb 3;29(3):559-73.
Rupture of vulnerable atherosclerotic plaques: microRNAs conducting the orchestra?
Haver VG, Slart RH, Zeebregts CJ, Peppelenbosch MP, Tio RA.
Trends Cardiovasc Med. 2010 Feb;20(2):65-71.
Novel mechanisms for the control of renin synthesis and release.
Sequeira Lopez ML, Gomez RA.
Curr Hypertens Rep. 2010 Feb;12(1):26-32.
MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-
overloaded adult hearts.
Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G, Diwan A, Nerbonne JM, Dorn GW 2nd.
Circ Res. 2010 Jan 8;106(1):166-75.
Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells.
Lee TH, Song SH, Kim KL, Yi JY, Shin GH, Kim JY, Kim J, Han YM, Lee SH, Lee SH, Shim SH, Suh W.
Circ Res. 2010 Jan 8;106(1):120-8.
Career moves: induced pluripotent cells from human aortic smooth muscle cells can efficiently redifferentiate into parental phenotype.
Kishore R, Krishnamurthy P, Losordo DW.
Circ Res. 2010 Jan 8;106(1):7-9.
The role of microRNA-133 in cardiac hypertrophy uncovered.
Abdellatif M.
Circ Res. 2010 Jan 8;106(1):16-8.
miRNA-processing enzyme Dicer is necessary for cardiac outflow tract alignment and chamber septation.
Saxena A, Tabin CJ.
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):87-91.
Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction.
Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Li Z, Yang B.
Biochem Biophys Res Commun. 2010 Jan 1;391(1):73-7.
MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
Pan ZW, Lu YJ, Yang BF.
Acta Pharmacol Sin. 2010 Jan;31(1):1-9.
The genetics of cardiovascular disease: new insights from emerging approaches.
Chico TJ, Milo M, Crossman DC.
J Pathol. 2010 Jan;220(2):186-97.
miR133a regulates cardiomyocyte hypertrophy in diabetes.
Feng B, Chen S, George B, Feng Q, Chakrabarti S.
Diabetes Metab Res Rev. 2010 Jan;26(1):40-9.
Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes.
Zhang Y, Zhang L, Chu W, Wang B, Zhang J, Zhao M, Li X, Li B, Lu Y, Yang B, Shan H.
Cell Physiol Biochem. 2010;26(6):991-8.
Identification and characteristics of microRNAs with altered expression patterns in a rat model of abdominal aortic aneurysms.
Liu G, Huang Y, Lu X, Lu M, Huang X, Li W, Jiang M.
Tohoku J Exp Med. 2010;222(3):187-93.
Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements.
Poller W, Fechner H.
Curr Pharm Des. 2010;16(20):2252-68.
Pathogenic mechanisms of congenital heart disease.
Huang JB, Liu YL, Lv XD.
Fetal Pediatr Pathol. 2010;29(5):359-72.
MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction.
Bostjancic E, Zidar N, Stajner D, Glavac D.
Folia Biol (Praha). 2010;56(1):27-31.
Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications.
Luo X, Zhang H, Xiao J, Wang Z.
Cell Physiol Biochem. 2010;25(6):571-86.
Expression profiles of miRNA-122 and its target CAT1 in minipigs (Sus scrofa) fed a high-cholesterol diet.
Cirera S, Birck M, Busk PK, Fredholm M.
Comp Med. 2010;60(2):136-41.
MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction.
Bostjancic E, Zidar N, Stajer D, Glavac D.
Cardiology. 2010;115(3):163-9.
MicroRNAs miR-1, -133 and -208: same faces, new roles.
Divakaran VG.
Cardiology. 2010;115(3):172-3.
The roles of microRNAs in heart diseases: a novel important regulator.
Cai B, Pan Z, Lu Y.
Curr Med Chem. 2010;17(5):407-11.
Pathway analysis of microRNAs in mouse heart development.
Liu G, Ding M, Wang H, Huang J, Jing Q, Shen B.
Int J Bioinform Res Appl. 2010;6(1):12-20.
Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection.
Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh MN, Lutgens E, Wang S, Olson
EN, Schober A, Weber C.
Sci Signal. 2009 Dec 8;2(100):ra81.
Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in
physiological and pathological conditions.
Elia L, Contu R, Quintavalle M, Varrone F, Chimenti C, Russo MA, Cimino V, De Marinis L, Frustaci A, Catalucci D, Condorelli G.
Circulation. 2009 Dec 8;120(23):2377-85.
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.
Lu Y, Zhang Y, Shan H, Pan Z, Li X, Li B, Xu C, Zhang B, Zhang F, Dong D, Song W, Qiao G, Yang B.
Cardiovasc Res. 2009 Dec 1;84(3):434-41.
Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation.
Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser SH, Ehrlich
JR.
Heart Rhythm. 2009 Dec;6(12):1802-9.
The ever-shrinking world of cardiac ion channel remodeling: the role of microRNAs in heart disease.
Duffy HS.
Heart Rhythm. 2009 Dec;6(12):1810-1.
Knockdown of microRNA-181 by lentivirus mediated siRNA expression vector decreases the arrhythmogenic effect of skeletal myoblast
transplantation in rat with myocardial infarction.
Li YG, Zhang PP, Jiao KL, Zou YZ.
Microvasc Res. 2009 Dec;78(3):393-404.
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human
disease.
Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, Peterson KL, Indolfi C, Catalucci D, Chen J, Courtneidge SA, Condorelli
G.
Cell Death Differ. 2009 Dec;16(12):1590-8.
MicroRNAs and beyond: the heart reveals its treasures.
Schroen B, Heymans S.
Hypertension. 2009 Dec;54(6):1189-94.
MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes.
Horie T, Ono K, Nishi H, Iwanaga Y, Nagao K, Kinoshita M, Kuwabara Y, Takanabe R, Hasegawa K, Kita T, Kimura T.
Biochem Biophys Res Commun. 2009 Nov 13;389(2):315-20.
Role of microRNA-214 in ginsenoside-Rg1-induced angiogenesis.
Chan LS, Yue PY, Mak NK, Wong RN.
Eur J Pharm Sci. 2009 Nov 5;38(4):370-7.
MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease.
Zhang C.
Cell Cycle. 2009 Nov 1;8(21):3469-73.
Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1.
Shan H, Li X, Pan Z, Zhang L, Cai B, Zhang Y, Xu C, Chu W, Qiao G, Li B, Lu Y, Yang B.
Br J Pharmacol. 2009 Nov;158(5):1227-35.
Adaptive and maladptive effects of SMAD3 signaling in the adult heart after hemodynamic pressure overloading.
Divakaran V, Adrogue J, Ishiyama M, Entman ML, Haudek S, Sivasubramanian N, Mann DL.
Circ Heart Fail. 2009 Nov;2(6):633-42.
A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.
van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN.
Dev Cell. 2009 Nov;17(5):662-73.
MicroRNAs as novel myocardial biomarkers.
Margulies KB.
Clin Chem. 2009 Nov;55(11):1897-9.
Plasma miR-208 as a biomarker of myocardial injury.
Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N.
Clin Chem. 2009 Nov;55(11):1944-9.
Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.
Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, Glaab WE.
Clin Chem. 2009 Nov;55(11):1977-83.
MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction.
Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES, Zhang C.
J Biol Chem. 2009 Oct 23;284(43):29514-25.
MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1.
Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R,
Federici M.
Circulation. 2009 Oct 13;120(15):1524-32.
Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks.
Naga Prasad SV, Duan ZH, Gupta MK, Surampudi VS, Volinia S, Calin GA, Liu CG, Kotwal A, Moravec CS, Starling RC, Perez DM, Sen
S, Wu Q, Plow EF, Croce CM, Karnik S.
J Biol Chem. 2009 Oct 2;284(40):27487-99.
MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2.
Chan SY, Zhang YY, Hemann C, Mahoney CE, Zweier JL, Loscalzo J.
Cell Metab. 2009 Oct;10(4):273-84.
MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury.
Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, Olson EN.
Genes Dev. 2009 Sep 15;23(18):2166-78.
Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure.
Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, Reinhardt F, Liao R, Krieger M, Jaenisch R, Lodish HF, Blelloch R.
Circ Res. 2009 Sep 11;105(6):585-94.
Role of specific microRNAs for endothelial function and angiogenesis.
Wu F, Yang Z, Li G.
Biochem Biophys Res Commun. 2009 Sep 4;386(4):549-53.
Non-cell-autonomous effects of vector-expressed regulatory RNAs in mammalian heart cells.
Kizana E, Cingolani E, Marbán E.
Gene Ther. 2009 Sep;16(9):1163-8.
Heart development before beating.
Nakajima Y, Sakabe M, Matsui H, Sakata H, Yanagawa N, Yamagishi T.
Anat Sci Int. 2009 Sep;84(3):67-76.
MicroRNA-modulated targeting of vascular smooth muscle cells.
Parmacek MS.
J Clin Invest. 2009 Sep;119(9):2526-8.
Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster.
Boettger T, Beetz N, Kostin S, Schneider J, Krüger M, Hein L, Braun T.
J Clin Invest. 2009 Sep;119(9):2634-47.
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.
Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang
DZ.
J Clin Invest. 2009 Sep;119(9):2772-86.
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity.
Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, Lee TH, Miano JM, Ivey KN, Srivastava D.
Nature. 2009 Aug 6;460(7256):705-10.
Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines.
Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai B, Wang N, Li X, Feng T, Hong Y, Yang B.
Cardiovasc Res. 2009 Aug 1;83(3):465-72.
MicroRNAs in cardiovascular biology and heart disease.
Catalucci D, Gallo P, Condorelli G.
Circ Cardiovasc Genet. 2009 Aug;2(4):402-8.
Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis.
van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, Baelde HJ, Monge M, Vos JB, de Boer HC, Quax
PH, Rabelink TJ, van Zonneveld AJ.
J Cell Mol Med. 2009 Aug;13(8A):1577-85.
MicroRNA is a new diagnostic and therapeutic target for cardiovascular disease and regenerative medicine.
Kaneda R, Fukuda K.
Circ J. 2009 Aug;73(8):1397-8.
Basic and translational research: from molecule, to mouse, to man.
Adams V, Möbius-Winkler S, Schuler G.
Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S48-52.
miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy.
Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li PF.
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12103-8.
MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation.
Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, Zhang C.
Circ Res. 2009 Jul 17;105(2):158-66.
Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a.
Kim GH, Samant SA, Earley JU, Svensson EC.
PLoS One. 2009 Jul 7;4(7):e6161.
MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDL-stimulated
monocyte/macrophages.
Chen T, Huang Z, Wang L, Wang Y, Wu F, Meng S, Wang C.
Cardiovasc Res. 2009 Jul 1;83(1):131-9.
Redox signalling and miRNA function in cardiomyocytes.
Brewer AC, Shah AM.
J Mol Cell Cardiol. 2009 Jul;47(1):2-4.
MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4.
Cheng Y, Liu X, Zhang S, Lin Y, Yang J, Zhang C.
J Mol Cell Cardiol. 2009 Jul;47(1):5-14.
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.
Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M,
Tjwa M, Urbich C, Zeiher AM, Dimmeler S.
Science. 2009 Jun 26;324(5935):1710-3.
DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.
Kuhn C, Frank D, Will R, Jaschinski C, Frauen R, Katus HA, Frey N.
J Biol Chem. 2009 Jun 19;284(25):17320-7.
[Mechanotransduction in cardiovascular and skeletal muscle]
Miyasaka K, Kida Y, Ogura T.
Seikagaku. 2009 Jun;81(6):494-501.
MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic
targets.
Silvestri P, Di Russo C, Rigattieri S, Fedele S, Todaro D, Ferraiuolo G, Altamura G, Loschiavo P.
Recent Pat Cardiovasc Drug Discov. 2009 Jun;4(2):109-18.
Role of microRNAs in cardiac hypertrophy and heart failure.
Wang N, Zhou Z, Liao X, Zhang T.
IUBMB Life. 2009 Jun;61(6):566-71.
MicroRNA control of muscle development and disease.
Williams AH, Liu N, van Rooij E, Olson EN.
Curr Opin Cell Biol. 2009 Jun;21(3):461-9.
MicroRNAs and cardiac pathology.
Latronico MV, Condorelli G.
Nat Rev Cardiol. 2009 Jun;6(6):419-29.
[Experimental analysis of microRNAs related to cardiac development differential expression]
Shi XX, Lai DD, Zhang JY, Chu MP, Wang SB, Ni QM, Huang XY, Zhang HQ, Yang DY.
Zhonghua Yi Xue Za Zhi. 2009 May 26;89(20):1416-20.
Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92
pathway.
Brock M, Trenkmann M, Gay RE, Michel BA, Gay S, Fischler M, Ulrich S, Speich R, Huber LC.
Circ Res. 2009 May 22;104(10):1184-91.
MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20.
Ren XP, Wu J, Wang X, Sartor MA, Qian J, Jones K, Nicolaou P, Pritchard TJ, Fan GC.
Circulation. 2009 May 5;119(17):2357-66.
Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease.
Minami Y, Satoh M, Maesawa C, Takahashi Y, Tabuchi T, Itoh T, Nakamura M.
Eur J Clin Invest. 2009 May;39(5):359-67.
MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2.
Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, Huang G.
Int Heart J. 2009 May;50(3):377-87.
MicroRNAs: regulating a change of heart.
Barringhaus KG, Zamore PD.
Circulation. 2009 Apr 28;119(16):2217-24.
Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction.
Shan ZX, Lin QX, Fu YH, Deng CY, Zhou ZL, Zhu JN, Liu XY, Zhang YY, Li Y, Lin SG, Yu XY.
Biochem Biophys Res Commun. 2009 Apr 17;381(4):597-601.
Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in
cardiac myocytes.
Rane S, He M, Sayed D, Vashistha H, Malhotra A, Sadoshima J, Vatner DE, Vatner SF, Abdellatif M.
Circ Res. 2009 Apr 10;104(7):879-86.
MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and
tensin homologue.
Roy S, Khanna S, Hussain SR, Biswas S, Azad A, Rink C, Gnyawali S, Shilo S, Nuovo GJ, Sen CK.
Cardiovasc Res. 2009 Apr 1;82(1):21-9.
MiRNA-21: a key to controlling the cardiac fibroblast compartment?
Haghikia A, Hilfiker-Kleiner D.
Cardiovasc Res. 2009 Apr 1;82(1):1-3.
Extracardiac approaches to protecting the heart.
Valen G.
Eur J Cardiothorac Surg. 2009 Apr;35(4):651-7.
MicroRNAs as a therapeutic target for cardiovascular diseases.
Mishra PK, Tyagi N, Kumar M, Tyagi SC.
J Cell Mol Med. 2009 Apr;13(4):778-89.
MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes.
Ikeda S, He A, Kong SW, Lu J, Bejar R, Bodyak N, Lee KH, Ma Q, Kang PM, Golub TR, Pu WT.
Mol Cell Biol. 2009 Apr;29(8):2193-204.
MicroRNA-221 regulates high glucose-induced endothelial dysfunction.
Li Y, Song YH, Li F, Yang T, Lu YW, Geng YJ.
Biochem Biophys Res Commun. 2009 Mar 27;381(1):81-3.
MicroRNA regulation of cardiovascular development.
Cordes KR, Srivastava D.
Circ Res. 2009 Mar 27;104(6):724-32.
Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells.
Lin Y, Liu X, Cheng Y, Yang J, Huo Y, Zhang C.
J Biol Chem. 2009 Mar 20;284(12):7903-13.
A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70.
Yin C, Salloum FN, Kukreja RC.
Circ Res. 2009 Mar 13;104(5):572-5.
Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by
biomechanical support.
Matkovich SJ, Van Booven DJ, Youker KA, Torre-Amione G, Diwan A, Eschenbacher WH, Dorn LE, Watson MA, Margulies KB, Dorn GW
2nd.
Circulation. 2009 Mar 10;119(9):1263-71.
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological
hypertrophy.
Suckau L, Fechner H, Chemaly E, Krohn S, Hadri L, Kockskämper J, Westermann D, Bisping E, Ly H, Wang X, Kawase Y, Chen J, Liang
L, Sipo I, Vetter R, Weger S, Kurreck J, Erdmann V, Tschope C, Pieske B, Lebeche D, Schultheiss HP, Hajjar RJ, Poller WC.
Circulation. 2009 Mar 10;119(9):1241-52.
miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha
and causing CaMKII-dependent hyperphosphorylation of RyR2.
Terentyev D, Belevych AE, Terentyeva R, Martin MM, Malana GE, Kuhn DE, Abdellatif M, Feldman DS, Elton TS, Györke S.
Circ Res. 2009 Feb 27;104(4):514-21.
A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia.
Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C.
Circ Res. 2009 Feb 27;104(4):476-87.
Ca(2+) signaling domains responsible for cardiac hypertrophy and arrhythmias.
Houser SR.
Circ Res. 2009 Feb 27;104(4):413-5.
MicroRNAs as novel regulators of angiogenesis.
Suárez Y, Sessa WC.
Circ Res. 2009 Feb 27;104(4):442-54.
[Prediction of the microRNAs related to cardiovascular diseases by bioinformatics]
Zhang F, Lu M, Zhang QP, Zhang FC, Gao W, Cui QH.
Beijing Da Xue Xue Bao. 2009 Feb 18;41(1):112-6.
Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype.
Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A.
J Biol Chem. 2009 Feb 6;284(6):3728-38.
MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2
diabetic rats.
Wang XH, Qian RZ, Zhang W, Chen SF, Jin HM, Hu RM.
Clin Exp Pharmacol Physiol. 2009 Feb;36(2):181-8.
RNA silencing: small RNA-mediated posttranscriptional regulation of mRNA and the implications for heart electropathophysiology.
Latronico MV, Condorelli G.
J Cardiovasc Electrophysiol. 2009 Feb;20(2):230-7.
Do microRNAs regulate myocardial fibrosis?
Díez J.
Nat Clin Pract Cardiovasc Med. 2009 Feb;6(2):88-9.
miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.
Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, Herias V, van Leeuwen RE, Schellings MW, Barenbrug P,
Maessen JG, Heymans S, Pinto YM, Creemers EE.
Circ Res. 2009 Jan 30;104(2):170-8
Searching for miR-acles in cardiac fibrosis.
van Rooij E, Olson EN.
Circ Res. 2009 Jan 30;104(2):138-40.
MicroRNAs: opening a new vein in angiogenesis research.
Fish JE, Srivastava D.
Sci Signal. 2009 Jan 6;2(52):pe1.
Insights into the role of microRNAs in cardiac diseases: from biological signalling to therapeutic targets.
Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, Beneyto M, Marín F, Gimeno JR, Osca J, Salvador A, España F, Estellés A.
Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):82-90.
Genetic markers for coronary artery disease.
Baudhuin LM.
Clin Lab Sci. 2009 Fall;22(4):226-32.
[Effects of RNA on blood circulation and its adrenergic and cholinergic regulation]
Neshcheret OP, Tkachuk ZIu, Moĭbenko OO.
Fiziol Zh. 2009;55(6):20-9.
MicroRNA microarray expression profiling in human myocardial infarction.
Bostjancic E, Zidar N, Glavac D.
Dis Markers. 2009;27(6):255-68.
MicroRNAs are involved in homocysteine-induced cardiac remodeling.
Mishra PK, Tyagi N, Kundu S, Tyagi SC.
Cell Biochem Biophys. 2009;55(3):153-62.
Micromanaging vascular biology: tiny microRNAs play big band.
Sen CK, Gordillo GM, Khanna S, Roy S.
J Vasc Res. 2009;46(6):527-40.
MicroRNA: novel regulators involved in the remodeling and reverse remodeling of the heart.
Wang J, Xu R, Lin F, Zhang S, Zhang G, Hu S, Zheng Z.
Cardiology. 2009;113(2):81-8.
Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice.
Yin C, Wang X, Kukreja RC.
FEBS Lett. 2008 Dec 24;582(30):4137-42.
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.
Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S, Castoldi M, Soutschek J,
Koteliansky V, Rosenwald A, Basson MA, Licht JD, Pena JT, Rouhanifard SH, Muckenthaler MU, Tuschl T, Martin GR, Bauersachs J,
Engelhardt S.
Nature. 2008 Dec 18;456(7224):980-4.
microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.
Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN.
Genes Dev. 2008 Dec 1;22(23):3242-54.
Right into the heart of microRNA-133a.
Meder B, Katus HA, Rottbauer W.
Genes Dev. 2008 Dec 1;22(23):3227-31.
Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support.
Schipper ME, van Kuik J, de Jonge N, Dullens HF, de Weger RA.
J Heart Lung Transplant. 2008 Dec;27(12):1282-5.
Expression, activity, and pro-hypertrophic effects of PDE5A in cardiac myocytes.
Zhang M, Koitabashi N, Nagayama T, Rambaran R, Feng N, Takimoto E, Koenke T, O'Rourke B, Champion HC, Crow MT, Kass DA.
Cell Signal. 2008 Dec;20(12):2231-6.
Downregulation of Dicer expression by serum withdrawal sensitizes human endothelial cells to apoptosis.
Asada S, Takahashi T, Isodono K, Adachi A, Imoto H, Ogata T, Ueyama T, Matsubara H, Oh H.
Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2512-21.
Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1.
Yu XY, Song YH, Geng YJ, Lin QX, Shan ZX, Lin SG, Li Y.
Biochem Biophys Res Commun. 2008 Nov 21;376(3):548-52.
Serum response factor orchestrates nascent sarcomerogenesis and silences the biomineralization gene program in the heart.
Niu Z, Iyer D, Conway SJ, Martin JF, Ivey K, Srivastava D, Nordheim A, Schwartz RJ.
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17824-9.
microRNA-138 modulates cardiac patterning during embryonic development.
Morton SU, Scherz PJ, Cordes KR, Ivey KN, Stainier DY, Srivastava D.
Proc Natl Acad Sci U S A. 2008 Nov 18;105(46):17830-5.
The emerging role of microRNAs in cardiac remodeling and heart failure.
Divakaran V, Mann DL.
Circ Res. 2008 Nov 7;103(10):1072-83.
Toward microRNA-based therapeutics for heart disease: the sense in antisense.
van Rooij E, Marshall WS, Olson EN.
Circ Res. 2008 Oct 24;103(9):919-28.
Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis.
Suárez Y, Fernández-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS, Iruela-Arispe ML, Merkenschlager M, Sessa WC.
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14082-7.
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis.
van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN.
Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13027-32.
Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve.
Xiao L, Xiao J, Luo X, Lin H, Wang Z, Nattel S.
Circulation. 2008 Sep 2;118(10):983-92.
Repolarization reserve: a moving target.
Roden DM.
Circulation. 2008 Sep 2;118(10):981-2.
MicroRNAs: novel regulators in cardiac development and disease.
Thum T, Catalucci D, Bauersachs J.
Cardiovasc Res. 2008 Sep 1;79(4):562-70.
Role of microRNAs in vascular diseases, inflammation, and angiogenesis.
Urbich C, Kuehbacher A, Dimmeler S.
Cardiovasc Res. 2008 Sep 1;79(4):581-8.
MicroRNAs: components of an integrated system controlling cardiac development, physiology, and disease pathogenesis.
Condorelli G, Dimmeler S.
Cardiovasc Res. 2008 Sep 1;79(4):551-2.
Control of cardiac excitability by microRNAs.
Yang B, Lu Y, Wang Z.
Cardiovasc Res. 2008 Sep 1;79(4):571-80.
[What's new in the couple thyroid and heart in 2008?]
François M, Delemer B.
Ann Endocrinol (Paris). 2008 Sep;69 Suppl 1:S37-43.
MicroRNA and cardiac pathologies.
Latronico MV, Catalucci D, Condorelli G.
Physiol Genomics. 2008 Aug 15;34(3):239-42.
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths.
Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M.
Mol Biol Cell. 2008 Aug;19(8):3272-82.
miRNA expression in the failing human heart: functional correlates.
Sucharov C, Bristow MR, Port JD.
J Mol Cell Cardiol. 2008 Aug;45(2):185-92.
On the road to the definition of the cardiac miRNome in human disease states.
Latronico MV, Condorelli G.
J Mol Cell Cardiol. 2008 Aug;45(2):162-4.
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.
Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, Richardson JA, Bassel-Duby R, Olson EN.
Dev Cell. 2008 Aug;15(2):261-71.
miR-126 regulates angiogenic signaling and vascular integrity.
Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D.
Dev Cell. 2008 Aug;15(2):272-84.
p100 increases AT1R expression through interaction with AT1R 3'-UTR.
Paukku K, Kalkkinen N, Silvennoinen O, Kontula KK, Lehtonen JY.
Nucleic Acids Res. 2008 Aug;36(13):4474-87.
Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart.
Luo X, Lin H, Pan Z, Xiao J, Zhang Y, Lu Y, Yang B, Wang Z.
J Biol Chem. 2008 Jul 18;283(29):20045-52.
[Perspective of microRNA in cardiovascular-associated diseases]
Zhang XB, Chen BS.
Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Jul;36(7):661-3.
miRNAs at the heart of the matter.
Wang Z, Luo X, Lu Y, Yang B.
J Mol Med. 2008 Jul;86(7):771-83.
Optimizing gene delivery vectors for the treatment of heart disease.
Gray SJ, Samulski RJ.
Expert Opin Biol Ther. 2008 Jul;8(7):911-22.
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3.
Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F.
J Biol Chem. 2008 Jun 6;283(23):15878-83.
Taking microRNAs to heart.
Callis TE, Wang DZ.
Trends Mol Med. 2008 Jun;14(6):254-60.
RNA induction and inheritance of epigenetic cardiac hypertrophy in the mouse.
Wagner KD, Wagner N, Ghanbarian H, Grandjean V, Gounon P, Cuzin F, Rassoulzadegan M.
Dev Cell. 2008 Jun;14(6):962-9.
MicroRNAs: role in cardiovascular biology and disease.
Zhang C.
Clin Sci (Lond). 2008 Jun;114(12):699-706.
Does the effect of microRNAs in vascular neointimal formation depend on cell cycle phase?
Silvestri P, Rigattieri S, Loschiavo P.
Circ Res. 2008 May 9;102(9):e101; author reply e102.
MicroRNAs flex their muscles.
van Rooij E, Liu N, Olson EN.
Trends Genet. 2008 Apr;24(4):159-66.
Pharmacological approaches to regenerative strategies for the treatment of cardiovascular diseases.
Pucéat M.
Curr Opin Pharmacol. 2008 Apr;8(2):189-92.
Implication of microRNAs in the cardiovascular system.
Scalbert E, Bril A.
Curr Opin Pharmacol. 2008 Apr;8(2):181-8.
MicroRNAs control gene expression: importance for cardiac development and pathophysiology.
Catalucci D, Latronico MV, Condorelli G.
Ann N Y Acad Sci. 2008 Mar;1123:20-9.
Evidence for the involvement of miRNA in redox regulated angiogenic response of human microvascular endothelial cells.
Shilo S, Roy S, Khanna S, Sen CK.
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):471-7.
The developmental genetics of congenital heart disease.
Bruneau BG.
Nature. 2008 Feb 21;451(7181):943-8.
Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure.
Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G,
Patterson C, Hannon GJ, Wang DZ.
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2111-6.
Muscling through the microRNA world.
Callis TE, Deng Z, Chen JF, Wang DZ.
Exp Biol Med (Maywood). 2008 Feb;233(2):131-8.
Inversion region for hypertension and brachydactyly on chromosome 12p features multiple splicing and noncoding RNA.
Bähring S, Kann M, Neuenfeld Y, Gong M, Chitayat D, Toka HR, Toka O, Plessis G, Maass P, Rauch A, Aydin A, Luft FC.
Hypertension. 2008 Feb;51(2):426-31.
Targeting microRNA expression to regulate angiogenesis.
Kuehbacher A, Urbich C, Dimmeler S.
Trends Pharmacol Sci. 2008 Jan;29(1):12-5.
Molecular regulation of cardiac hypertrophy.
Barry SP, Davidson SM, Townsend PA.
Int J Biochem Cell Biol. 2008;40(10):2023-39.
Heart failure: targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment.
Latronico MV, Elia L, Condorelli G, Catalucci D.
Int J Biochem Cell Biol. 2008;40(9):1643-8.
An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133.
Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN.
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20844-9.
Emerging role of microRNAs in cardiovascular biology.
Latronico MV, Catalucci D, Condorelli G.
Circ Res. 2007 Dec 7;101(12):1225-36.
[MicroRNAs can be expressed in cardiomyocyte-like cells differentiated from human mesenchymal stem cells]
Shan ZX, Lin QX, Yu XY, Deng CY, Li XH, Zhang XC, Liu XY, Fu YH.
Nan Fang Yi Ke Da Xue Xue Bao. 2007 Dec;27(12):1813-6.
Serum response factor micromanaging cardiogenesis.
Niu Z, Li A, Zhang SX, Schwartz RJ.
Curr Opin Cell Biol. 2007 Dec;19(6):618-27.
Altered microRNA expression in human heart disease.
Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT.
Physiol Genomics. 2007 Nov 14;31(3):367-73.
microRNAs put their signatures on the heart.
van Rooij E, Olson EN.
Physiol Genomics. 2007 Nov 14;31(3):365-6.
MicroRNAs in the broken heart.
Bauersachs J, Thum T.
Eur J Clin Invest. 2007 Nov;37(11):829-33.
The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9
in cardiomyocytes.
Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z, Yang B.
J Cell Sci. 2007 Sep 1;120(Pt 17):3045-52.
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.
van Rooij E, Olson EN.
J Clin Invest. 2007 Sep;117(9):2369-76.
Transcriptional activation by stimulating protein 1 and post-transcriptional repression by muscle-specific microRNAs of IKs-encoding
genes and potential implications in regional heterogeneity of their expressions.
Luo X, Xiao J, Lin H, Li B, Lu Y, Yang B, Wang Z.
J Cell Physiol. 2007 Aug;212(2):358-67.
MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure.
Thum T, Galuppo P, Wolf C, Fiedler J, Kneitz S, van Laake LW, Doevendans PA, Mummery CL, Borlak J, Haverich A, Gross C, Engelhardt
S, Ertl G, Bauersachs J.
Circulation. 2007 Jul 17;116(3):258-67.
Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis.
Kuehbacher A, Urbich C, Zeiher AM, Dimmeler S.
Circ Res. 2007 Jul 6;101(1):59-68.
Resizing the genomic regulation of restenosis.
Matsumoto T, Hwang PM.
Circ Res. 2007 Jun 8;100(11):1537-9.
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion
formation.
Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C.
Circ Res. 2007 Jun 8;100(11):1579-88.
MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?
Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C.
Am J Pathol. 2007 Jun;170(6):1831-40.
Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.
Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, Rojas M, Hammond SM, Wang DZ.
J Mol Cell Cardiol. 2007 Jun;42(6):1137-41.
MicroRNA-133 controls cardiac hypertrophy.
Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Hoydal M,
Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G.
Nat Med. 2007 May;13(5):613-8.
MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts.
Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N, Zhang Y, Yang B, Wang Z.
J Biol Chem. 2007 Apr 27;282(17):12363-7.
Control of stress-dependent cardiac growth and gene expression by a microRNA.
van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN.
Science. 2007 Apr 27;316(5824):575-9.
Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells.
Suarez Y, Fernandez-Hernando C, Pober JS, Sessa WC.
Circ Res. 2007 Apr 27;100(8):1164-73.
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.
Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, Tsuchihashi T, McManus MT, Schwartz RJ, Srivastava D.
Cell. 2007 Apr 20;129(2):303-17.
miR-1-2 gets to the heart of the matter.
Mishima Y, Stahlhut C, Giraldez AJ.
Cell. 2007 Apr 20;129(2):247-9.
The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2.
Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z.
Nat Med. 2007 Apr;13(4):486-91.
MicroRNA may have macro effect on sudden death.
Anderson ME, Mohler PJ.
Nat Med. 2007 Apr;13(4):410-1.
MicroRNAs in skeletal and cardiac muscle development.
Callis TE, Chen JF, Wang DZ.
DNA Cell Biol. 2007 Apr;26(4):219-25.
MicroRNAs play an essential role in the development of cardiac hypertrophy.
Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M.
Circ Res. 2007 Feb 16;100(3):416-24.
Thoracic skeletal defects and cardiac malformations: a common epigenetic link?
Weston AD, Ozolins TR, Brown NA.
Birth Defects Res C Embryo Today. 2006 Dec;78(4):354-70.
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.
van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN.
Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18255-60.
MicroRNA1 influences cardiac differentiation in Drosophila and regulates Notch signaling.
Kwon C, Han Z, Olson EN, Srivastava D.
Proc Natl Acad Sci U S A. 2005 Dec 27;102(52):18986-91.
Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis.
Zhao Y, Samal E, Srivastava D.
Nature. 2005 Jul 14;436(7048):214-20.
Developmental biology: tiny brakes for a growing heart.
Bruneau BG.
Nature. 2005 Jul 14;436(7048):181-2.